Even More Evidence for the Value of Early HPV Vaccination
Even More Evidence for the Value of Early HPV Vaccination An exciting new study in Scotland found no cases of invasive cervical cancer in young women who had gotten the HPV vaccine by the time they were 14. The study also found that women vaccinated between ages 14 and 22 had lower rates of cervical […]
Celebrating Cervical Health Awareness Month in January
Cervical Health Awareness Month in January is a time to learn about cervical health and cancer prevention. The World Health Organization has a plan for the elimination of cervical cancer through vaccination and screening—we can get there!
Is One Shot of the HPV Vaccine Enough? New Study Shows Promising Results
Is one shot enough? A new study adds to evidence that one dose of the HPV vaccine might be enough to provide protection against cervical cancer.
Too Few People Understand the Link Between HPV and Cancer
A new study revealed a disturbing trend in health knowledge; fewer people seem to understand the connection between HPV and certain types of cancer including cervical, oral, anal, and penile cancers.
Cervical Health Awareness Month Social Media Toolkit
Celebrate Cervical Health Awareness Month in January by sharing our content on your social media channels. Use your voice to promote cervical cancer prevention.
Social Media Toolkit on Cervical Health
If you’re passionate about cervical health awareness, the resources here are for you. Advocacy around cervical health is especially relevant during national observances, including Cervical Health Awareness Month in January.
Runneth Over—An Online Theater Presentation
ASHA is thrilled to partner with Elevate Theatre Company on this online theater event, Runneth Over. Runneth Over by Sabrina Jacob Washburn. explores themes of women’s sexual health, cervical cancer prevention, HPV and HPV vaccinations.
HPV-Related Cancer
According to the Centers for Disease Control and Prevention (CDC), about 36,500 HPV-associated cancers occur in the U.S each year.
FDA Approves HPV Vaccine for Adults Over 26
[post_date] On October 5, 2018 the FDA approved use of the Gardasil 9 HPV vaccine in males and females ages 27-45, expanding the previous indication that covered from ages 9-26. Gardasil 9 prevents infections with the “high risk” HPV types most commonly found in a number of cancers worldwide, including cervical cancer. The vaccine also […]
Study Says Cervical Cancer Death Rates Are Far Higher Than We Thought
New research finds that women in the U.S. are dying from cervical cancer at rates far higher than we realized, especially with black women.